Conversion surgery for locally advanced malignant pleural mesothelioma

Gen Thorac Cardiovasc Surg. 2020 Dec;68(12):1547-1550. doi: 10.1007/s11748-020-01329-y. Epub 2020 Mar 12.

Abstract

Two women in their sixties were diagnosed with inoperable locally advanced epithelioid malignant pleural mesothelioma, c-stage IIIB. Post-chemotherapy, the tumors down-staged to yc-stage IA, and pleurectomy/decortication were performed. The pathological diagnoses were p-stages II and IA. One patient had tumor recurrence 6 months after surgery; she is currently undergoing fourth-line chemotherapy and is alive 30 months postoperatively. The second patient had tumor recurrence 4 months after surgery and died 2 months later. Conversion surgery for advanced malignant mesothelioma does not improve progression-free survival but might have a chance to extend overall survival in selected patients without deteriorating performance status.

Keywords: Chemotherapy; Conversion surgery; Locally advanced; Malignant pleural mesothelioma; Pleurectomy/decortication.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antineoplastic Agents / therapeutic use
  • Combined Modality Therapy
  • Female
  • Humans
  • Mesothelioma, Malignant / diagnostic imaging
  • Mesothelioma, Malignant / pathology
  • Mesothelioma, Malignant / surgery*
  • Middle Aged
  • Neoplasm Recurrence, Local / drug therapy
  • Neoplasm Recurrence, Local / pathology*
  • Pleura / surgery
  • Pleural Neoplasms / diagnostic imaging
  • Pleural Neoplasms / pathology
  • Pleural Neoplasms / surgery*
  • Survival Analysis
  • Thoracic Surgical Procedures
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Antineoplastic Agents